AzTrials
AzTrials

Aortic AneurysmSEMPERNCT01985906

Safety and Efficacy of Multiple Overlapping Uncovered Stents for Pararenal Aortic Aneurysm Repair

A study testing Multiple overlapping uncovered stents and Uncovered stents in people with Aortic Aneurysm and Aortic Aneurysm, Abdominal, run by Changhai Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Complex aortic aneurysms involving major branches have been difficult endovascularly. The primary purposes of this study is to evaluate the safety, feasibility, and efficacy of multiple overlapping uncovered stents in treating aortic aneurysm while preserving major visceral branches, including the celiac artery (CA)… Read more about this study

Who is it for?
Ages 18 to 90 years
What is being tested?
Multiple overlapping uncovered stents and Uncovered stents
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteChina
Study dates
May 2014to Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age>18 years
  • Life expectancy ≥ 12 months
  • The patient or his legal representative has signed the informed consent form
  • Contraindicated for open surgery, declared inoperable by surgeon and anesthetist (statement signed by each doctor) and must have at least one of the following:
  • Age>80 years
  • ASA ≥3
Show all 20Show fewer
  • history of thoracic surgery or surgery of abdominal aorta
  • coronary artery disease (history of angina myocardial infarction) with positive functional testing and coronary lesions for which revascularization is impossible or not indicated
  • heart failure
  • LVEF < 40%
  • chronic respiratory failure defined by one of the following criteria:
  • FEV1 <1.2 L/sec;
  • VC <50% of the predicted value according to age, sex and weight;
  • Arterial blood gas analysis in the absence of oxygen: PaCO2>45 mmHg or PaO2 < 60 mmHg;
  • Oxygen therapy.
  • renal insufficiency if creatininaemia> 200 micromol/L before injection of contrast product;
  • hostile abdomen, including presence of ascites or other signs of portal hypertension;
  • obesity.
  • Conventional tubular stent-graft is not suitable due to complicated aneurysm anatomy, such as being adjacent to (proximal or distal landing zone < 15mm) or involving vital branches, including the celiac artery, superior mesenteric artery, or renal artery.
  • Adequate arterial anatomy of aneurismal lesion access.

Who cannot join

  • Medical contraindications to a local or general anesthesia and angiography;
  • Life expectancy less than one year, or clinical follow-up impossible;
  • Congenital disorders of blood coagulation;
  • Intercurrent infection;
  • Allergy to aspirin, clopidogrel, or contrast agents;
  • Patient (s) included in another clinical study;
  • Patient pregnant or breastfeeding.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Division of Vascular Surgery, Changhai Hospital

    Shanghai, 200433

    Qingsheng Lu, MD, +86 021 31161662, vascsurg.ch@xueguan.net

    Yongxue Zhang, MD, +86 13671856162, zhangyx0807@yahoo.com

    Recruiting

Other trials in China

About this study

Official title: Evaluation of the Safety and Efficacy of Multiple Overlapping Uncovered Stents for Endovascular Pararenal Aortic Aneurysm Repair

Complex aortic aneurysms involving major branches have been difficult endovascularly. The primary purposes of this study is to evaluate the safety, feasibility, and efficacy of multiple overlapping uncovered stents in treating aortic aneurysm while preserving major visceral branches, including the celiac artery (CA), superior mesenteric artery (SMA) and renal artery (RA).

Read the detailed description

The traditional endovascular treatment of aneurysms is based on the utilization of stent-grafts that create a mechanical barrier between the aneurysmal sac and normal blood flow. Problems such as endoleak and occlusion of collateral arteries impede its application in complex aneurysms adjacent to or involving vital branches. Advanced branched/fenestrated endografts have been applied in many experienced centers, but the application of these techniques is limited in less-experienced centers due to the complicated and cumbersome nature of these procedures.

The concept of using bare metal stents to occlude aneurysms was firstly described about two decades ago. Geremia et al suggested that a metallic stent bridging a saccular aneurysm would alter the local flow pattern, promoting thrombus formation, thereby leading to aneurysm occlusion. Optimal flow modulation effect is reached with a mean stent porosity of 65%. To achieve such low mesh porosity while maintaining the flexibility of the stent, the investigators applied multiple stents in an overlapping fashion. Computational simulation in this study has demonstrated that with 3 or 4 bare metal stents deployed, the mesh porosity could be decreased to an effective value, slowing flow velocity within the sac. The use of overlapping stents has been reported in the treatment of peripheral aneurysms with satisfactory clinical outcome.

The primary purposes of this study is to evaluate the safety, feasibility, and efficacy of multiple overlapping uncovered stents in treating aortic aneurysm while preserving major visceral branches, including the celiac artery (CA), superior mesenteric artery (SMA) and renal artery (RA).

Being tested
Multiple overlapping uncovered stents, Uncovered stents
Keywords
Aorta, Aneurysm, Stents, Collateral Circulation
Medical subject headings
Aortic Aneurysm, Aortic Aneurysm, Abdominal, Aortic Aneurysm, Thoracic, Aortic Aneurysm, Thoracoabdominal, Aneurysm

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multiple overlapping uncovered stentsProcedure or surgery

    Endovascular management of complex aortic aneurysms with multiple overlapping uncovered stents

  • Uncovered stentsDevice

    Also called Bare stents, Bare metal stents

    The number of uncovered stents implanted was determined by intraoperative angiography with the criterion that a decrease of velocity in the aneurysmal sac was achieved. Side branches, including segmental arteries and visceral branches, were covered wherever necessary.

Study groups in NCT01985906
Study groupRoleWhat they receive
Pararenal aortic aneurysmExperimentalThe aneurysm is adjacent to (proximal/distal landing zone < 15mm) or involving vital branches, including the celiac artery, superior mesenteric artery, or renal artery. The intervention is endovascular management of the aneurysms with multiple overlapping uncovered stents
Receives: Procedure: Multiple overlapping uncovered stents; Device: Uncovered stents

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients with aneurysm exclusion

    Aneurysm exclusion means that the aneurysm shrinks or stays stable over time.

    Measured: 12 months

Secondary outcomes (2)
  1. Number of patent major branches within the coverage zone

    Major branches include the celiac artery, superior mesenteric artery, or renal artery.

    Measured: 12 months

  2. Number of patients with serious adverse events

    Adverse events include aneurysm-related, procedure-related, and stent-related complications or mortality

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2013 (estimated)
  2. Study startMay 2014
  3. Primary completionOct 2020 (estimated)
  4. Study completionOct 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01985906
Sponsor's protocol ID
MOUS-AP0807
Other IDs
81170291
Acronym
SEMPER
Status last verified
May 2014
First submitted
7 Nov 2013
Last updated
6 May 2014
Results posted
No
Data monitoring committee
Yes

Publications

  • Zhang YX, Lu QS, Feng JX, Zhao ZQ, Bao JM, Feng R, Feng X, Jing ZP. Endovascular management of pararenal aortic aneurysms with multiple overlapping uncovered stents. J Vasc Surg. 2013 Sep;58(3):616-23. doi: 10.1016/j.jvs.2013.02.248. Epub 2013 May 25.

    PubMed 23714363
  • Zhang YX, Lu QS, Jing ZP. Multilayer stents, a new progress in the endovascular treatment of aneurysms. Chin Med J (Engl). 2013 Feb;126(3):536-41.

    PubMed 23422121
  • Zhang YX, Lu QS, Jing ZP. Innovative sandwich technique in treating a symptomatic saccular suprarenal aneurysm involving the celiac trunk. Vasc Endovascular Surg. 2013 Feb;47(2):102-5. doi: 10.1177/1538574412471210. Epub 2012 Dec 27.

    PubMed 23275483
  • Geremia G, Haklin M, Brennecke L. Embolization of experimentally created aneurysms with intravascular stent devices. AJNR Am J Neuroradiol. 1994 Aug;15(7):1223-31.

    PubMed 7976930
  • Sfyroeras GS, Dalainas I, Giannakopoulos TG, Antonopoulos K, Kakisis JD, Liapis CD. Flow-diverting stents for the treatment of arterial aneurysms. J Vasc Surg. 2012 Sep;56(3):839-46. doi: 10.1016/j.jvs.2012.04.020. Epub 2012 Jul 26.

    PubMed 22840737
  • Benndorf G, Campi A, Schneider GH, Wellnhofer E, Unterberg A. Overlapping stents for treatment of a dissecting carotid artery aneurysm. J Endovasc Ther. 2001 Dec;8(6):566-70. doi: 10.1177/152660280100800605.

    PubMed 11797969
  • Hurst RW, Haskal ZJ, Zager E, Bagley LJ, Flamm ES. Endovascular stent treatment of cervical internal carotid artery aneurysms with parent vessel preservation. Surg Neurol. 1998 Oct;50(4):313-7; discussion 317. doi: 10.1016/s0090-3019(97)00461-8.

    PubMed 9817452
  • Klein GE, Szolar DH, Raith J, Fruhwirth H, Pascher O, Hausegger KA. Posttraumatic extracranial aneurysm of the internal carotid artery: combined endovascular treatment with coils and stents. AJNR Am J Neuroradiol. 1997 Aug;18(7):1261-4.

    PubMed 9282852
  • Uchino H, Asano T, Nakayama N, Kuroda S, Houkin K. [Flow diversion by double-overlapping-stent for fusiform vertebral artery aneurysm: a case report]. No Shinkei Geka. 2011 Jan;39(1):59-63. Japanese.

    PubMed 21270480
  • Ruiz-Juretschke F, Castro E, Mateo Sierra O, Iza B, Manuel Garbizu J, Fortea F, Villoria F. Massive epistaxis resulting from an intracavernous internal carotid artery traumatic pseudoaneurysm: complete resolution with overlapping uncovered stents. Acta Neurochir (Wien). 2009 Dec;151(12):1681-4. doi: 10.1007/s00701-009-0294-5. Epub 2009 Apr 7.

    PubMed 19350203
  • Ozturk MH, Eyuboglu I, Pulathan Z, Dinc H. Spontaneous thrombosis of a saccular iliac artery aneurysm induced by overlapping self-expandable bare metallic stents. Diagn Interv Radiol. 2010 Dec;16(4):308-11. doi: 10.4261/1305-3825.DIR.2422-08.0. Epub 2009 Oct 19.

    PubMed 19838982

Questions about this trial

What is this clinical trial studying?

A study testing Multiple overlapping uncovered stents and Uncovered stents in people with Aortic Aneurysm and Aortic Aneurysm, Abdominal, run by Changhai Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 20 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 May 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Qingsheng Lu, MD (+86 021 31161662, vascsurg.ch@xueguan.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients with aneurysm exclusion (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01985906, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in